✦ LIBER ✦

Pharmacokinetics and efficacy of darunavir/ritonavir once daily in virologically suppressed, treatment-experienced HIV-infected children

✍ Scribed by Chokephaibulkit, K; Rungmaitree, S; Phongsamart, W; Lappra, K; Wittawatmongkol, O; Kongstan, N; Cressey, TR

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics, Efficacy, and Safety o

✍ Boffito, Marta; Miralles, Diego; Hill, Andrew 📂 Article 📅 2008 🏛 Thomas Land Publishers, Inc. 🌐 English ⚖ 194 KB

Final 192-week efficacy and safety of on

✍ Orkin, C; DeJesus, E; Khanlou, H; Stoehr, A; Supparatpinyo, K; Lathouwers, E; Le 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 303 KB

Switching to darunavir/ritonavir 800/100

✍ Ghosn, Jade; Slama, Laurence; Chermak, Aziza; Houssaini, Allal; Lambert-Niclot, 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

PIN19 ECONOMICAL EVALUATION OF DARUNAVIR

✍ P Vorobiev; M Avksentieva; M Lesnicheva 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

Efficacy of dual therapy with lamivudine

✍ Casado, J. L.; Banon, S.; Rodriguez, M. A.; Santiuste, C.; Perez-Elias, M. J.; M 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 127 KB

Efficacy, tolerability and risk factors

✍ J Young; AU Scherrer; HF Günthard; M Opravil; S Yerly; J Böni; M Rickenbach; CA 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB